Can-Fite BioPharma Ltd. Increase (Decrease) in Accounts Payable, Trade
Can-Fite BioPharma Ltd. (CANF) reported Increase (Decrease) in Accounts Payable, Trade of $543.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-03-26
| Period end | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|
| 2025-12-31 | $543.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $534.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $191.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $458.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | -$469.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | -$86.00K 6-K · filed 2024-08-29 | |
| 2022-12-31 | -$58.00K 20-F · filed 2025-04-14 | |
| 2022-06-30 | -$130.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $393.00K 20-F · filed 2024-03-28 | |
| 2021-06-30 | $444.00K 6-K · filed 2022-08-25 | |
| 2020-12-31 | -$1.59M 20-F · filed 2023-03-30 | |
| 2020-06-30 | -$1.72M 6-K · filed 2021-08-26 | |
| 2019-12-31 | $1.08M 20-F · filed 2022-03-24 | |
| 2019-06-30 | $439.00K 6-K · filed 2020-08-27 | |
| 2018-12-31 | $644.00K 20-F · filed 2021-03-25 | |
| 2017-12-31 | $293.00K 6-K · filed 2020-06-01 |